216 related articles for article (PubMed ID: 30720426)
1. FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cells.
Javidi-Sharifi N; Martinez J; English I; Joshi SK; Scopim-Ribeiro R; Viola SK; Edwards DK; Agarwal A; Lopez C; Jorgens D; Tyner JW; Druker BJ; Traer E
Elife; 2019 Feb; 8():. PubMed ID: 30720426
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
[TBL] [Abstract][Full Text] [Related]
3. Activation of the FGF2/FGFR1 autocrine loop for cell proliferation and survival in uveal melanoma cells.
Lefèvre G; Babchia N; Calipel A; Mouriaux F; Faussat AM; Mrzyk S; Mascarelli F
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1047-57. PubMed ID: 19029025
[TBL] [Abstract][Full Text] [Related]
4. Activation of the FGF2-FGFR1 autocrine pathway: a novel mechanism of acquired resistance to gefitinib in NSCLC.
Terai H; Soejima K; Yasuda H; Nakayama S; Hamamoto J; Arai D; Ishioka K; Ohgino K; Ikemura S; Sato T; Yoda S; Satomi R; Naoki K; Betsuyaku T
Mol Cancer Res; 2013 Jul; 11(7):759-67. PubMed ID: 23536707
[TBL] [Abstract][Full Text] [Related]
5. FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc.
Nakayama T; Mutsuga N; Tosato G
Blood; 2007 Feb; 109(4):1363-72. PubMed ID: 17077327
[TBL] [Abstract][Full Text] [Related]
6. Blockade of FGF2/FGFR2 partially overcomes bone marrow mesenchymal stromal cells mediated progression of T-cell acute lymphoblastic leukaemia.
Tian C; Li Y; Wang L; Si J; Zheng Y; Kang J; Wang Y; You MJ; Zheng G
Cell Death Dis; 2022 Nov; 13(11):922. PubMed ID: 36333298
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
[TBL] [Abstract][Full Text] [Related]
8. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
[TBL] [Abstract][Full Text] [Related]
9. Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells.
Corrado C; Raimondo S; Saieva L; Flugy AM; De Leo G; Alessandro R
Cancer Lett; 2014 Jun; 348(1-2):71-6. PubMed ID: 24657661
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells.
Chi F; Griffiths JI; Nath A; Bild AH
Breast Cancer Res; 2024 Mar; 26(1):54. PubMed ID: 38553760
[TBL] [Abstract][Full Text] [Related]
11. FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination.
Mierzwa AJ; Zhou YX; Hibbits N; Vana AC; Armstrong RC
Neurosci Lett; 2013 Aug; 548():280-5. PubMed ID: 23684572
[TBL] [Abstract][Full Text] [Related]
12. DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10-FGFR2 signaling.
Yu S; Ye J; Wang Y; Lu T; Liu Y; Liu N; Zhang J; Lu F; Ma D; Gale RP; Ji C
J Biol Chem; 2023 Jan; 299(1):102787. PubMed ID: 36509141
[TBL] [Abstract][Full Text] [Related]
13. Leukemia-derived exosomes induced IL-8 production in bone marrow stromal cells to protect the leukemia cells against chemotherapy.
Chen T; Zhang G; Kong L; Xu S; Wang Y; Dong M
Life Sci; 2019 Mar; 221():187-195. PubMed ID: 30716336
[TBL] [Abstract][Full Text] [Related]
14. FGF2 from Marrow Microenvironment Promotes Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia.
Traer E; Martinez J; Javidi-Sharifi N; Agarwal A; Dunlap J; English I; Kovacsovics T; Tyner JW; Wong M; Druker BJ
Cancer Res; 2016 Nov; 76(22):6471-6482. PubMed ID: 27671675
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast Growth Factor-2 facilitates the growth and chemo-resistance of leukemia cells in the bone marrow by modulating osteoblast functions.
Sugimoto K; Miyata Y; Nakayama T; Saito S; Suzuki R; Hayakawa F; Nishiwaki S; Mizuno H; Takeshita K; Kato H; Ueda R; Takami A; Naoe T
Sci Rep; 2016 Aug; 6():30779. PubMed ID: 27481339
[TBL] [Abstract][Full Text] [Related]
16. GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression.
Santolla MF; Vivacqua A; Lappano R; Rigiracciolo DC; Cirillo F; Galli GR; Talia M; Brunetti G; Miglietta AM; Belfiore A; Maggiolini M
Cells; 2019 Mar; 8(3):. PubMed ID: 30866584
[TBL] [Abstract][Full Text] [Related]
17. Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1.
Hu Y; Guimond SE; Travers P; Cadman S; Hohenester E; Turnbull JE; Kim SH; Bouloux PM
J Biol Chem; 2009 Oct; 284(43):29905-20. PubMed ID: 19696444
[TBL] [Abstract][Full Text] [Related]
18. Effect of fibroblast growth factor 2 on degenerative endplate chondrocyte: From anabolism to catabolism.
Song H; Du H; Li J; Wang M; Wang J; Ju X; Mu W
Exp Mol Pathol; 2021 Feb; 118():104590. PubMed ID: 33285208
[TBL] [Abstract][Full Text] [Related]
19. The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival.
Hu Y; Mintz A; Shah SR; Quinones-Hinojosa A; Hsu W
Carcinogenesis; 2014 Jul; 35(7):1491-9. PubMed ID: 24445144
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation.
Koo HY; El-Baz LM; House S; Cilvik SN; Dorry SJ; Shoukry NM; Salem ML; Hafez HS; Dulin NO; Ornitz DM; Guzy RD
J Pathol; 2018 Sep; 246(1):54-66. PubMed ID: 29873400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
